References
- Feng RN, Li Y, Sun CH (2009). TNF 308 G/A polymorphism and type 1 diabetes: a meta-analysis, Diabetes Res Clin Pract, 85, e4-7. https://doi.org/10.1016/j.diabres.2009.04.026
- Gorouhi F, Islami F, Bahrami H, et al (2008). Tumournecrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis, Br J Cancer 98, 1443-51. https://doi.org/10.1038/sj.bjc.6604277
- Javor J, Ferencik S, Bucova M, et al (2010). Polymorphisms in the genes encoding TGF-beta1, TNF-alpha, and IL-6 show association with type 1 diabetes mellitus in the Slovak population. Arch Immunol Ther Exp(Warsz), 58, 385-93. https://doi.org/10.1007/s00005-010-0092-z
- Yang Y, Feng R, Bi S, et al (2011a). TNF-alpha polymorphisms and breast cancer, Breast Cancer Res Treat. https://doi.org/10.1007/s10549-011-1494-2
- Yang Y, Luo C, Feng R, et al (2011b). The TNF-alpha, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol, 137, 947-52. https://doi.org/10.1007/s00432-010-0959-8
- Zhou P, Lv GQ, Wang JZ, et al (2011). The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis. PLoS One, 6, e22092. https://doi.org/10.1371/journal.pone.0022092
Cited by
- Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk vol.31, pp.3, 2015, https://doi.org/10.1185/03007995.2015.1011778